SNS Antagonists Flashcards
Describe the effects of each type of adrenoceptor.
α1:
- Vasoconstriction
- Relaxation of GIT
α2:
- Inhibition of neurotransmitter release
- Contraction of vascular smooth muscle
- CNS actions
β1:
- Increased cardiac rate and force
- Relaxation of GIT
- Renin release from kidney.
β2:
- Brochodilation
- Vasodilation
- Relaxation of visceral smooth muscle
- Hepatic glycogenolysis
β3:
- Lipolysis
Explain the adrenergic receptors present at a synapse.
- NA released into synaptic cleft
- NA binds to adrenergic receptor on effector (e.g. α1 on vascular smooth muscle cells)
- The presynaptic neurone also contains autoreceptors
- They also bind to NA
- Their function is to monitor the NT environment within the synapse
- This influences release of further NTs
- When NA binds to presynaptic α2 receptors, it inhibits further release of NA from the presynaptic nerve terminal by negative feedback

State five adrenoceptor antagonists including the receptors that they block.
- Carvedilol - non-selective (α1+ β1)
- Non-selective refers to the fact that they are non-selective to just alpha or beta
- Block both adrenergic receptor types
- Phentolamine - α1+ α2
- Prazosin - α1
- Propranolol - β1 + β2
- Atenolol - β1
State four main clinical uses of adrenoceptor antagonists.
- Hypertension
- Angina
- Arrhythmia
- Glaucoma
Which equation is used to determine blood pressure.
Blood Pressure (BP) = Cardiac Output (CO) x Total Peripheral Resistance (TPR)
NOTE: When we refer to blood pressure we are referring to the arterial pressure
State three elements that contribute to hypertension.
Blood volume
Cardiac output
Vascular tone
What is defined as hypertension?
Having a BP consistently above 140/90 mmHg
Why is hypertenson so dangerous and what is the main goal of treating it?
- Single most important risk factor for stroke, causing about 50% of ischaemic strokes
- Accounts for approx. 25% of heart failure (HF) cases, this increases to approx. 70% in the elderly
- Major risk factor for myocardial infarction (MI) & chronic kidney disease (KD)
Ultimate goal of hypertension therapy is to reduce mortality from cardiovascular or renal events
What are the tissue targets for anti-hypertensive drugs? State the receptors of each tissue that beta blockers would target.
Sympathetic nerves:
- The ones to BVs release the vasoconstrictor noradrenaline
Kidneys:
- Regulates blood volume and vasoconstriction (via RAAS)
Heart:
- Determines CO
Arterioles:
- Determine peripheral resistance (TPR)
CNS:
- Determines blood pressure set point
- Regulates some systems involved in BP control & ANS
State the receptors of each tissue that beta blockers would target.
Anti-hypertensive actions of beta blockers primarily mediated by blockade of β1 receptors
Kidneys - β1:
- Reduced renin production
Heart - β1:
- Reduced CO
- This effect disappears in chronic treatment (probably some kind of tolerance mechanism)
Arterioles - not targeted:
- Vasoconstriction is α1 mediated, so generally cannot be targeted by beta blockers
- Generally, you don’t want to target the α1 receptors and cause vasodilation as a first-line of treatment due to side-effects (e.g. reflex tachycardia)
Sympathetic nerves - β1/β2:
- There are some beta receptors on sympathetic nerves - less knowledge out there on this
CNS - β1/β2:
- Some beta receptors in brain tied to CNS control of blood pressure - less knowledge out there on this
- Reduction in sympathetic tone
Arterioles - not targeted:
- You don’t want to target the α1 receptors and cause just vasodilation as a first-line of treatment due to side-effects (e.g. reflex tachycardia)
Describe the mechanism of action of beta blockers in treating hypertension.
Through β1 blockade:
- ↓ in HR & FOC (SV) - ↓ in CO
- Reduction in CO means reduction in BP
- Thsi also means that the heart does not have to work as hard
- ↓ renin - ↓ angiotensin II (Ang II) release
- Ang II - potent vasoconstrictor & increases aldosterone production (leads to increase in blood volume)
- *Blockade of the facilitatory effects of presynaptic β-adrenoceptors on noradrenaline release may also contribute to the antihypertensive effect
- Essentially means presynaptic β-adrenoceptors facilitates/stimulates NA release
Name some different beta-blockers and state their selectivity.

State four conditions in which you would not give a patient a betablocker. Explain each of them.
Asthma – blockade of beta 2 receptors in the lungs can take away the beta 2 mediated bronchodilation, which can be fatal in asthmatics Cardiac Failure – these patients rely on a certain degree of sympathetic drive to the heart to maintain adequate cardiac output COPD – same reason as asthma Diabetes – beta blockade masks the symptoms of hypoglycaemia (e.g. tremors, palpitations, sweating) and beta 2 blockade also inhibits hepatic glycogenolysis
State some other unwanted effects of beta-blockers.
Bronchoconstriction
- Bronchodilation is mediated by the SNS via β2- receptors
- Blockage → bronchoconstriction
- This isn’t important in the absence of airway disease
- BUT could be dangerous is someone with asthma (life-threatening) or obstructive lung disease such as COPD
- Airway already obstructed, so don’t want to cause further bronchoconstriction and obstruction
Cardiac failure
- Patients with heart disease may rely on a degree of sympathetic drive to the heart to maintain an adequate cardiac output
- Removal of this by blocking β−receptors will produce a degree of cardiac failure (i.e. insufficient CO)
Hypoglycaemia
- Glucose release from the liver is controlled by β2- receptors
- Glycogenolysis and gluconeogenesis → HGO
- Blockage → reduced HGO and hypoglycaemia
- The use of β-antagonists could also mask the symptoms of hypoglycemia (sweating, palpitations, tremor)
- These symptoms are sympathetic effects - SNS stimulated during hypoglycaemia
- Beta blockers blocking SNS in general
Fatigue
- Due to reduced cardiac output and reduced muscle perfusion
- Loss of β2 mediated vasodilation to increase blood flow to skeletal muscle during times of increased need/usage (e.g. exercise)
Cold Extremities (i.e. hands and feet)
- Loss of β2-receptor mediated vasodilation in cutaneous vessels
- Function of this in ‘fight or flight’ is to keep you cool overall - heat radiating away from blood into environment
- Vasoconstriction → reduced blood supply → reduced warmth (as blood has a role in heat transfer to tissues)
Bad dreams
What is the advantage of atenolol over propranolol?
Propanolol:
- Non-selective beta blocker
- ‘Equal’ affinity for β1 & β2 receptors
- Therefore could cause β2 mediated unwanted effects
Atenolol:
- β1-selective beta blocker - i.e. cardioselective
- More selective for β1 receptors
- Therefore β2 mediated unwanted effects less likely
- BUT although it has less effect on airways than non-selective drugs, but still not safe with asthmatic patients
Why would you still not give a β1-selective beta blocker to an asthmatic patient?
Selectivity is concentration dependent
- Selectivity decreases as concentration increases
What advantage does carvedilol have over atenolol and propranolol?
- Carvedilol is a dual acting β1 and α1 antagonists
- Higher ratio of β1 to α1 (4:1).
- Like β-blockers, carvedilol, induces a change in heart rate or cardiac output (but this effect decreases with chronic use)
- However, due to the α1 blockade, this drug also lowers blood pressure via a reduction in peripheral resistance
- Blocks α1 mediated vasoconstriction
What types of receptors are α1 and α2 adrenoceptors and where are they found.
All adrenoceptors are G-protein coupled receptors
α1-receptors:
- Gq-linked
- Postsynaptic on vascular smooth muscle
α2-receptors:
- Gi-linked
- Presynaptic autoreceptors inhibiting NA release
Give some examples of different types of alpha blockers and when they are used.
Phentolamine:
- Non-selective α-blocker
- Used to treat phaechromocytoma-induced hypertension
- Phaechromocytoma = catecholamine secreting tumour of adrenal medulla
- Too much adrenaline and NA
Prazosin:
- α1 specific blocker
- Inhibits the vasoconstrictor activity of NA
- Has modest blood pressure lowering effects
- Not as powerful antihypertensive as phentolamine
- Not very clear why this is
- Only used as adjunctive treatment
- Used to assist a primary treatment of hypertenion
State some of the problems with non-selective alpha blockers (e.g. phentolamine).
- You would get a fall in arterial pressure
- Alpha 1-adrenoceptors main mediators of peripheral resistance
- Vasodilation → reduced TPR → reduced BP
- This would lead to postural hypotension
- The main response to prevent postural hypotension is peripheral vasoconstriction ( TPR) which increases MAP
- This is due to blood pooling in the distensible/compliant veins when you have been sitting down
Cardiac output/heart rate increases -
- Baroreceptor mediated reflex tachycardia
- This reflex response to fall in arterial pressure (mediated by the beta-adrenoceptors)
- This is due to blockade of the alpha 2 receptors which would increase NA release
Other side effects:
- Increased GI motility → diarrhoea
- This makes sense because you are blocking alpha receptors
- Alpha receptors are involved in reduction of GI motility and tone
- Blood flow through cutaneous & splanchnic vascular beds increased
- Alpha receptors are involved in sphinter contraction to reduce blood flow to GI tract
- Cutaneous vasoconstriction mediated by alpha 1 receptors
- But effects on vascular smooth muscle are slight - i.e. these effects are slight
Phentolamine no longer in clinical use
What are the effects of prazosin?
Prazosin is highly selective for alpha 1 receptors.
- This leads to vasodilation and fall in arterial pressure
This should in theory be more effective than phentolamine (not understood why not) because:
- Less tachycardia than non-selective antagonists since they do not increase noradrenaline release from nerve terminals - i.e. no alpha 2 actions actions
- Cardiac output decreases, due to fall in venous pressure as a result of dilation of capacitance vessels
- Reduced EDV → reduced preload → reduced force of contraction (SV) → reduced CO
Describe the mechanism of action of methyldopa.
Methyldopa is an antihypertensive agent
- Methyldopa is taken up by the noradrenergic neurons
- It is decarboxylates and hydroxylated to form the false transmitter: alpha-methyl noradrenaline
- It is NOT deaminated (i.e. broken down) within the neuron by MAO so tends to accumulate in larger quantities than noradrenaline in the pre-synaptic terminal
- MAO breaks down NA inside the pre-synaptic termina into metabolites
- It displaces noradrenaline from the synaptic vesicles
- There is more of the false transmitter so it is more likely to be packaged into vesicles than NA
- Hence it is displacing NA
- The false transmitter (alpha-methyl noradrenaline) is released in the same way as noradrenaline
- So more false transmitter and less NA is released
- It is less active than noradrenaline on alpha-1 receptors
- i.e. less efficacy
- This means that it is LESS EFFECTIVE AT CAUSING VASOCONSTRICTION
- Reduced TPR → reduced BP
- Also, it is more powerful on presynaptic alpha-2 receptors
- This means that the auto-inhibitory feedback mechanism operates more strongly and reduces noradrenaline release below normal levels
- This means that even less NA is being released so even less NA to compete with the false transmitter for the alpha 1 receptors
- So this allows an even greater proportion of the alpha 1 receptors to be occupied by the false transmitter rather than NA
State some other benefits of methyldopa other than its effect as an anti-hypertensive.
By bieng less effecive at vasoconstriction and thereby reduces TPR → improved blood flow
Other treatment uses:
- Renal - kidney disease
- Improving blood flow to kidneys increases the amount of blood getting filtered
- This helps reduce build-up of toxic substances or waste products in the blood
- CNS - cerebrovascular disease
-
Problem with blood vessels affects blood supply to brain
- Most commonly ischaemia due to narrowing of arteries (atherosclerosis) or a blood clot
- So vasodilation and widening of the BVs could help counteract this problem and improve blood supply
-
Problem with blood vessels affects blood supply to brain
What are some adverse effects of methyldopa?
- Dry mouth
- Reduced alpha-adrenoceptor stimulation inhibits salivary secretion
- Sedation
- NA involved in control of arousal in the brain so lack of NA effect/activity results in sedation
- Orthostatic hypotension
- reduced TPR
- Male sexual dysfunction
- Alpha and beta adrenergic pathway involved in regulating erectile function
- So disruption causes dysfunction




